Abivax

ABVXNasdaq France Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.272 B

$130.93 +0.71%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

78,536,412

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#30Corcept TherapeuticsCORT$12.0B
#31Madrigal PharmaceuticalsMDGL$11.8B
#32AbivaxABVX$11.3B
#33Summit TherapeuticsSMMT$11.1B
#34Elanco Animal HealthELAN$11.1B

Where these numbers come from

Share counts and financials for Abivax are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.